Short trial durations exacerbate these issues, often yielding “improvement trends,” or “improvements that did not reach statistical significance,” which may be a reflection of these limitations, but also an indication of the lack of sensitivity of the measures used.
← all excerpts
Clinical and cognitive assessment in Friedreich ataxia clinical trials: a review.
1
—
—